Related Experiment Video
Updated: Jan 4, 2026

Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for In Vivo Phenotyping and Drug Monitoring
Published on: June 23, 2015
Change in Dyslipidemia with Declining Glomerular Filtration Rate and Increasing Proteinuria in Children with CKD
Jeffrey M Saland1, Juan C Kupferman2, Christopher B Pierce3
1Division of Pediatric Nephrology, Icahn School of Medicine at Mount Sinai, New York, New York.
Insights
Dyslipidemia is common in children with chronic kidney disease (CKD) and worsens with declining kidney function, increased proteinuria, and higher body mass index (BMI). These lipid changes are linked to CKD progression, impacting cardiovascular risk.
Area of Science:
- Pediatric Nephrology
- Cardiovascular Risk Factors
- Lipid Metabolism
Background:
- Dyslipidemia is a known cardiovascular disease risk factor, frequently observed in children with chronic kidney disease (CKD).
- The longitudinal changes in dyslipidemia and its relationship with CKD progression in pediatric populations have not been well-described.
Purpose of the Study:
- To prospectively investigate the temporal relationship between lipid changes and CKD progression in children.
- To quantify how changes in glomerular filtration rate (GFR), proteinuria, and body mass index (BMI) influence lipid profiles over time in pediatric CKD.
Main Methods:
- Prospective cohort study (CKD in Children) of 508 children with progressive CKD.
- Utilized multivariable linear mixed-effects models to analyze longitudinal changes in lipids (HDL, non-HDL cholesterol, triglycerides) against GFR, proteinuria, and BMI.
- Median follow-up of 4 years with 2-6 lipid measurements per child.
Main Results:
- Dyslipidemia was prevalent at baseline (35-43%) and increased with age, particularly in children with glomerular CKD.
- Increased proteinuria correlated with higher non-HDL cholesterol and triglycerides.
- Declining GFR was associated with decreased HDL cholesterol (nonglomerular CKD) and increased non-HDL cholesterol (glomerular CKD).
- Increased BMI showed significant associations with lipid changes, especially in glomerular CKD.
Conclusions:
- Dyslipidemia is a persistent complication in pediatric CKD, worsening with disease progression.
- Declining GFR, increasing proteinuria, and rising BMI are independently associated with adverse lipid changes in children with CKD.
- These findings highlight the need for monitoring and managing dyslipidemia in pediatric CKD to mitigate cardiovascular risk.
Background And Objectives:
Dyslipidemia, a risk factor for cardiovascular disease, is common in CKD but its change over time and how that change is influenced by concurrent progression of CKD have not been previously described.
Design, Setting, Participants, & Measurements:
In the CKD in Children study we prospectively followed children with progressive CKD and utilized multivariable, linear mixed-effects models to quantify the longitudinal relationship between within-subject changes in lipid measures (HDL cholesterol, non-HDL cholesterol, triglycerides) and within-subject changes in GFR, proteinuria, and body mass index (BMI).
Results:
A total of 508 children (76% nonglomerular CKD, 24% glomerular CKD) had 2-6 lipid measurements each, with a median follow-up time of 4 (interquartile range [IQR], 2.1-6.0) years. Among children with nonglomerular CKD, dyslipidemia was common at baseline (35%) and increased significantly as children aged; 43% of children with glomerular CKD had dyslipidemia at baseline and demonstrated persistent levels as they aged. Longitudinal increases in proteinuria were independently associated with significant concomitant increases in non-HDL cholesterol (nonglomerular: 4.9 [IQR, 3.4-6.4] mg/dl; glomerular: 8.5 [IQR, 6.0-11.1] mg/dl) and triglycerides (nonglomerular: 3% [IQR, 0.8%-6%]; glomerular: 5% [IQR, 0.6%-9%]). Decreases in GFR over follow-up were significantly associated with concomitant decreases of HDL cholesterol in children with nonglomerular CKD (-1.2 mg/dl; IQR, -2.1 to -0.4 mg/dl) and increases of non-HDL cholesterol in children with glomerular CKD (3.9 mg/dl; IQR, 1.4-6.5 mg/dl). The effects of increased BMI also affected multiple lipid changes over time. Collectively, glomerular CKD displayed stronger, deleterious associations between within-subject change in non-HDL cholesterol (9 mg/dl versus 1.2 mg/dl; P<0.001) and triglycerides (14% versus 3%; P=0.004), and within-subject change in BMI; similar but quantitatively smaller differences between the two types of CKD were noted for associations of within-subject change in lipids to within-subject change in GFR and proteinuria.
Conclusions:
Dyslipidemia is a common and persistent complication in children with CKD and it worsens in proportion to declining GFR, worsening proteinuria, and increasing BMI.
Related Concept Videos
Nephrotic Syndrome I : Introduction
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease III: Interprofessional Care
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
Nephrotic Syndrome II : Assessment and Medical Management

